If you’re in a regulated industry of some kind – financial services, for instance, or healthcare – how would you use a tool like a public blog as a means to engage with people you want to connect with, and that doesn’t cross any regulatory line?
One company that’s successfully addressing this is pharmaceutical giant GlaxoSmithKline in the USA with its ‘More Than Medicine’ blog launched in May 2009.
Looking through the blog will give you a good sense of how GSK in the US addresses topical healthcare issues, including engaging with blog visitors via comments to posts. Reading ‘About this blog’ will give you a very good idea of how GSK US sees this medium.
For deeper background and insight into their thinking, listen to this WeissWatch ThoughtLeaders podcast interview I conducted a few days ago with Michael Fleming, head of new and social media communications for GSK US Pharmaceuticals.
- Listen to or download the podcast (MP3, 8.1Mb, 17:38)
Michael talks about the overall goals and objectives he has for the blog, as well as the learnings and experience his company has gained in the nine months since the blog launched. In our conversation, Michael also comments on the FDA hearing into regulated healthcare communication and social media that took place last November and the implications for healthcare communications in the United States (and, potentially, in other countries).
The example of GSK USA makes it clearer to see what’s possible with social media communication in a regulated business environment.
[Disclosure: The WeissWatch ThoughtLeaders podcast is part of the WeissWatch Podcast and a product of WCG, the company where I am Head of Social Media in Europe. We didn’t work with GSK on their blog.]
15 responses to “GSK’s healthcare blog doesn’t cross the line”
[Blog] GSK’s healthcare blog doesn't cross the line http://tinyurl.com/y9h6bm4 #fb #in
Full marks. their UK counterparts should take note.
I worked with a number of gsk brands on digital marketing bits but never managed to get anything away with even a free comment area because of compliance issues etc.
It came to the point where we actually resigned the accounts.
Overcoming the fear factor is part of the mindset shift re social media in a regulatory environment, imo.
jedb this podcast might interest you. http://is.gd/6bMi3
Thanks Neville! RT @Jangles GSK’s healthcare blog doesn't cross the line http://tinyurl.com/y9h6bm4 #fb #in
GSKã®ãƒ–ãƒã‚°ã§ã™ã€‚　RT @GSKUS: Thanks Neville! RT @Jangles GSK’s healthcare blog doesn't cross the line http://tinyurl.com/y9h6bm4 #fb #in
RT: @GSKUS Thanks Neville! RT @Jangles GSK’s healthcare blog doesn't cross the line http://tinyurl.com/y9h6bm4 #fb #in
RT @jangles GSK's healthcare blog doesn't cross the line http://tinyurl.com/y9h6bm4
[…] This post was mentioned on Twitter by Neville Hobson, Neville Hobson, Glaxo GSK US, Brian Gould, Shincat and others. Shincat said: GSKã®ãƒ–ãƒã‚°ã§ã™ã€‚　RT @GSKUS: Thanks Neville! RT @Jangles GSK’s healthcare blog doesn't cross the line http://tinyurl.com/y9h6bm4 #fb #in […]
GSK's healthcare blog doesn't cross the line | NevilleHobson.com http://bit.ly/7sEPNb
GSK's healthcare blog doesn't cross the line | NevilleHobson.com http://bit.ly/6VJQWI
GSK's healthcare blog doesn't cross the line | NevilleHobson.com http://bit.ly/4sY1FA
GSK’s healthcare blog: podcast interview http://bit.ly/5ltLoo
[…] an example of good execution, look to GSK’s healthcare blog [hat tip, Neville Hobson]. The blog gained momentum thanks to solid planning and consistency. If they can do it, you can, […]
A much wiser idea is to take a long hard look at the entire health insurance industry and then work to remedy the situation by taking out the waste and creating new, innovative ideas that would be a benefit for all.
Thank you for sharing this post.